Psychosocial and pharmacological interventions for the treatment of cannabis use disorder
Abstract Cannabis use has been continuously increasing, and cannabis use disorder (CUD) has become a public health issue. Some psychosocial…
Bernard Le Foll
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial
Abstract Background: The current lack of pharmacological treatments for cannabis use disorder (CUD) warrants novel approaches and further investigation of…
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling
Abstract It is estimated that 0.6–1% of the population in the USA and Canada fulfil the Diagnostic and Statistical Manual…
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol
Abstract Objective: Acute administration of cannabinoid CB1 receptor agonists, or the ingestion of cannabis, induces short-term hyperphagia. However, the incidence…
Role of the Endogenous Cannabinoid System in Nicotine Addiction: Novel Insights
Abstract Several lines of evidence have shown that the endogenous cannabinoids are implicated in several neuropsychiatric diseases. Notably, preclinical and…